Vaxil Bio Ltd (VXL) — Cash Flow-to-Debt Ratio

Latest as of September 2025: -3.50x

Vaxil Bio Ltd (VXL) has a Cash Flow-to-Debt Ratio of -3.50x as of September 2025, meaning its operating cash flow of CA$-28.00K could theoretically repay -4% of its total liabilities (CA$8.00K) in one year. See VXL free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

CF-to-Debt Ratio

-3.50x
Operating CF / Total Liabilities

Operating Cash Flow

CA$-28.00K
CAD

Total Liabilities

CA$8.00K
CAD

Data as of

Sep 2025
Most recent filing

Vaxil Bio Ltd Cash Flow-to-Debt Ratio (2009–2024)

Historical debt coverage capacity for Vaxil Bio Ltd across 16 annual periods. For the full cash flow conversion analysis, see Vaxil Bio Ltd cash flow conversion.

Annual Cash Flow-to-Debt Ratio for Vaxil Bio Ltd (2009–2024)

Year-by-year debt coverage analysis for Vaxil Bio Ltd. Check VXL cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Year CF-to-Debt Ratio Operating CF (CAD) Total Liabilities YoY Change
2024 -14.12x CA$-240.00K CA$17.00K ▼ -113.9%
2023 -6.60x CA$-561.00K CA$85.00K ▼ -264.2%
2022 -1.81x CA$-734.00K CA$405.00K ▲ +2.2%
2021 -1.85x CA$-1.08 Million CA$585.00K ▼ -44.0%
2020 -1.29x CA$-1.10 Million CA$857.00K ▼ -70.2%
2019 -0.76x CA$-596.00K CA$788.00K ▲ +63.5%
2018 -2.07x CA$-943.00K CA$455.00K ▼ -65.0%
2017 -1.26x CA$-1.00 Million CA$797.00K ▲ +53.0%
2016 -2.67x CA$-1.50 Million CA$561.00K ▼ -117.0%
2015 -1.23x CA$-624.00K CA$507.00K ▲ +22.3%
2014 -1.58x CA$-128.91K CA$81.35K ▲ +73.1%
2013 -5.90x CA$-383.44K CA$64.99K ▼ -614.5%
2012 -0.83x CA$-164.34K CA$199.02K ▲ +82.1%
2011 -4.62x CA$-457.76K CA$99.17K ▲ +53.6%
2010 -9.96x CA$-380.10K CA$38.17K ▼ -99.3%
2009 -5.00x CA$-145.03K CA$29.03K —
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.